Skip to main content
. 2021 Jul 28;7(8):e07666. doi: 10.1016/j.heliyon.2021.e07666

Table 6.

Progression of the series of cancer drugs.

PubChem (CID) Category and drug APOD Score (Benefits-Risks) N-APOD (WRGLSBADMET)
Weak safety profile
1 9884685  PI-103 3–5 67255934534
2 11669062  PI-540 4–4 88246935533
Moderate safety profile
3 17755052  GDC-0941 5–3 99239947531